Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PBYI > SEC Filings for PBYI > Form 8-K on 1-Nov-2013All Recent SEC Filings

Show all filings for PUMA BIOTECHNOLOGY, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for PUMA BIOTECHNOLOGY, INC.


1-Nov-2013

Other Events


Item 8.01 Other Events.

On October 28, 2013, in connection with a routine review of the compliance of Puma Biotechnology, Inc. (the "Company") with the New York Stock Exchange ("NYSE") Listed Company Manual, the NYSE requested that the Company clarify and supplement certain disclosures in its proxy statement for the 2013 Annual Meeting of Stockholders (the "2013 Proxy Statement") as described below.

Presiding Director. Thomas R. Malley presides over the regularly scheduled executive sessions of the non-management directors.

Communication with the Board of Directors. The procedure for stockholders to communicate with the board of directors included in the 2013 Proxy Statement is also the procedure for other interested parties:

Stockholders and other interested parties may send communications to the Company's board of directors, including any individual director, any non-management director or the directors as a group, by mailing such communications to Puma Biotechnology, Inc., 10880 Wilshire Boulevard, Suite 2150, Los Angeles, California 90024, Attention: Corporate Secretary. Such correspondence shall be addressed to the board of directors, any individual director or any non-management director by either name or title.

All communications received as set forth in the preceding paragraph will be opened by the Company's Corporate Secretary for the sole purpose of determining whether the contents represent a message to the Company's directors. Any contents that are not in the nature of advertising, promotions of a product or service, or patently offensive material will be forwarded promptly to the addressee. In the case of communications to the board of directors, any individual director or any non-management director, the Company's Corporate Secretary will make sufficient copies of the contents to send to each director to which the envelope is addressed.

Corporate Governance Guidelines. The Company previously adopted corporate governance guidelines and the guidelines are available on the Company's corporate website at www.pumabiotechnology.com/about_governance.html. The inclusion of the Company's website address in this Current Report does not include or incorporate by reference the information on the Company's website into this Current Report.

Disclosure of the items described above will be made going forward in the Company's future annual meeting proxy statements, as well as in any other filings requiring such disclosures.


  Add PBYI to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PBYI - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.